Filing Details
- Accession Number:
- 0001209191-23-021573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-30 09:11:05
- Reporting Period:
- 2023-03-29
- Accepted Time:
- 2023-03-30 09:11:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1287098 | Maxcyte Inc. | MXCT | Biological Products, (No Disgnostic Substances) (2836) | MA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021015 | Richard Douglas | C/O Maxcyte, Inc. 9713 Key West Avenue, Suite 400 Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-29 | 80,000 | $4.32 | 100,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
